Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsDefinium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder in a second successful late-stage study for the...
For patients with small-cell lung cancer, skipping preventive cranial radiotherapy in favor of MRI monitoring may improve outcomes.
1.
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975
2.
Are ultramarathon runners really at increased risk of bowel cancer?
3.
Cancer screening rates down among American adults
4.
One-third of childhood cancer survivors experience significant fear that it could come back, study reveals
5.
Research has shown that Ga-68 FAPI PET enhances pancreatic cancer detection and staging.
1.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
2.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
3.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
4.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
5.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge